The tele-epilepsy market size is estimated to be USD 328.85 million in 2022 and is expected to witness a CAGR of 15.92% during the forecast period 2023-2033. Rising prevalence of epilepsy in adult and paediatric populations, soaring epilepsy cases, rising usage of mobile and internet service, technological developments, and lower treatment costs are some of the factors contributing to the market growth. Furthermore, rising government initiatives and increase in funding for telemedicine start-ups from private companies are other factors supporting the market growth. However, lack of awareness and strict government regulations is expected to hinder the growth.

Rising government initiatives is expected to fuel the market growth during the projected period. Governments all across the world are launching initiatives to expand the tele-epilepsy market. For instance, by introducing new regulations and reimbursement requirements, numerous governmental institutions are embracing telehealth. The US Federal Communications Commission created programmes in March 2020 to help healthcare companies adopting telemedicine technology.

Increase in funding for telemedicine start-ups from private companies is predicted to spur the market growth during the forecast period. In the first quarter of 2020, capital investment for telemedicine companies increased to $788 million. According to communications and research company Mercom Capital Group, that level of funding is more than triple the $220 million telemedicine start-ups raised in the first quarter of 2019. Funding for telemedicine increased by 258% annually.

Segmentation

By Patient

The market is categorized into adult and pediatric. In 2022, the adult segment accounted for the highest revenue share due to the rise in the adult population and severity. Adults with epilepsy are more likely to experience severe problems after seizures, which increases the case for tele-epilepsy. The tele-epilepsy market is divided into adult and pediatric categories based on the patients. The paediatric segment is expected to grow at a significant CAGR during the projection period. Pediatric epilepsy cases differ from adult cases in terms of seizure type and epilepsy syndrome due to their stronger immune levels and lower susceptibility to other diseases. For instance, pediatric patients frequently distinguish between juvenile convulsions and epileptic syndromes including Lennox-Gastaut disorder, children absence epilepsy, and Dravet syndrome.

By Component

The market is categorized into service, software, and hardware. In the global market, the hardware segment accounted for the largest revenue share in 2022 owing to widespread usage of videoconferencing technology, microphones, audio equipment, and other medical accessories to facilitate virtual visits. For instance, the official NeuroLynQ service procedure for central location research was introduced by IVP Research Labs, Schlesinger Group, and Shimmer Research in March 2021. It provides a remote biometric tracking device that enables users’ unconscious human emotions to be evaluated while they are at home. The service segment is projected to expand at a substantial CAGR due to the expansion of solutions for remote patient monitoring. The growing use of teleconsulting between patients and clinicians will boost the segment’s expansion. For instance, Eagle Telemedicine announced the start of its TeleHospitalist and TeleNocturnist programmes at the Jersey Community Hospital in September 2019.

By End User

The market is segmented into healthcare consumers, hospital providers, and payers. In 2022, the hospital providers segment accounted for the largest revenue share owing to government’s investment of medical facilities in hospitals across various areas, rise in patient volume, ease and diversity of products available in one location. Additionally, hospitals that encourage patients to purchase their drugs on hospital premises are more inclined to support the market. Furthermore, all patients can easily visit hospitals as they are around. The healthcare consumer segment is positioned to see increase in the use of teleconsultation services owing to effectiveness and efficiency of online consultations, and advantage of receiving treatment in an emergency from their location.

Regional Markets

In 2022, North America region accounted for the highest revenue in the tele-epilepsy market and is expected to maintain its dominance during the forecast period. This is attributed to its technologically advanced infrastructure, increasing epilepsy rates, and rising per capita income. Additionally, the region’s expansion is being aided by the existence of several market players and supportive government laws. For instance, the U.S. Federal Communications Commission created efforts in March 2020 to support healthcare companies in deploying telemedicine technology. Asia Pacific is predicted to grow throughout the evaluation period due to the extensive use of cutting-edge technology, improved network connectivity, rising prevalence of epilepsy cases, and expanded government programme offerings. For instance, the Psychiatric Gap Action Program and the Myanmar WHO Program established in February 2022 to close the epilepsy treatment gap were successful in accomplishing their goals.

Competitor Insights

Some of the key players operating in the tele-epilepsy market are Empatica, Eagle Telemedicine, Science Soft USA Corporation, Sevaro, Chiron Health, Shimmer, SOC Telemed, Tele Specialists, RTTC, and Vidyo, Inc.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

• The official NeuroLynQ service procedure for central location research was introduced in March 2021 by IVP Research Labs, Schlesinger Group, and Shimmer Research. The NeuroLynQ service offers a remote biometric tracking device to evaluate customers’ unconscious human emotions while they are at home.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including patient, component, and end user from 2023 to 2033.

Report Scope:

Segmentation: Tele-Epilepsy Market Report 2022 – 2033

Patient (Revenue, USD Million), 2022 – 2033

• Adult
• Pediatric

Component (Revenue, USD Million), 2022 – 2033

• Service
• Software
• Hardware

End user (Revenue, USD Million), 2022 – 2033

• Healthcare Consumers
• Hospital Providers
• Payers

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA